MindMed has taken a significant step forward in the development of innovative treatments for Generalised Anxiety Disorder (GAD), announcing...
Read MoreBeckley Psytech has unveiled promising topline results from its Phase 2a study of ELE-101, a groundbreaking synthetic intravenous (IV)...
Read MoreSuntory Beverage & Food GB&I (SBF GB&I), the producer of household favourites Lucozade and Ribena, has announced a transformative...
Read MoreMinoryx Therapeutics and Neuraxpharm Group have announced a significant breakthrough in the treatment of cerebral adrenoleukodystrophy (cALD) in paediatric...
Read MoreBayer has officially begun a Phase 1 clinical trial for BAY3498264, an investigational oral selective SOS1 inhibitor designed to...
Read MoreDudley-based pork pie maker T.C. Morris has taken a significant step forward in its journey, securing a five-figure funding...
Read More